HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

mNGS for identifying pathogens in febrile neutropenic children with hematological diseases.

AbstractOBJECTIVE:
To investigate the application value of metagenomic next-generation sequencing (mNGS) in children with hematological diseases presenting with Febrile Neutropenia (FN).
METHODS:
We retrospectively analyzed the clinical data of 49 hematological children with FN, and compared the results of mNGS with those of traditional pathogen detection (TPD) and the prognoses of mNGS positive group and negative group.
RESULTS:
A total of 77 pathogenic strains were identified, of which 70 strains were detected by mNGS, 19 strains by TPD, and Aspergillus and G- bacterias were the predominant strains in FN children who developed bloodstream infections. 42 cases were in the mNGS-positive group, of which 17 were simple infections, 25 were mixed infections, and 7 were in the negative group; the TPD-positive group contained 19 cases, all of which were simple infections. The detection rate of total and mixed pathogens was higher than that of TPD, and the difference was statistically significant (P<0.05). The mNGS positive group was detected earlier than the negative group, and with lower mortality and drug-related adverse events (DRAE), and the difference was statistically significant (P<0.05).
CONCLUSION:
For FN children with hematological diseases, early mNGS can effectively improve the efficacy of pathogen detection, and precise treatment after clarifying the pathogens can reduce mortality and avoid antibiotic abuse.
AuthorsFang Guo, Lei Kang, Lin Zhang
JournalInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (Int J Infect Dis) Vol. 116 Pg. 85-90 (Mar 2022) ISSN: 1878-3511 [Electronic] Canada
PMID34929357 (Publication Type: Journal Article)
CopyrightCopyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Topics
  • Child
  • Febrile Neutropenia (diagnosis)
  • Hematologic Diseases (complications)
  • High-Throughput Nucleotide Sequencing (methods)
  • Humans
  • Metagenomics (methods)
  • Retrospective Studies
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: